Advantech Capital L.P. - 08 Jul 2025 SCHEDULE 13D/A Report for SINOVAC BIOTECH LTD. Common Shares (SVA)

Filing Manager
Advantech Capital L.P.
Reporting Manager
Advantech Capital L.P.
Symbol
SVA
Shares outstanding
71,884,803 shares
Disclosed Ownership
5,851,423 shares
Ownership
8.1%
Form type
SCHEDULE 13D/A
Filing time
14 Jul 2025, 06:16:50 UTC
Date of event
08 Jul 2025
Previous filing
10 Apr 2025

Quoteable Key Fact

"Advantech Capital L.P. disclosed 8.1% ownership in SINOVAC BIOTECH LTD. Common Shares (SVA) on 08 Jul 2025."

Quick Takeaways

  • Advantech Capital L.P. filed SCHEDULE 13D/A for SINOVAC BIOTECH LTD. Common Shares (SVA).
  • Disclosed ownership: 8.1%.
  • Date of event: 08 Jul 2025.

What Changed

  • Previous schedule filing date: 10 Apr 2025.
  • Current filing was accepted on 14 Jul 2025, 06:16.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Advantech Capital L.P. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory 0001650757
Advantech Capital Partners Ltd. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory
Green Vision Partners Limited 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Director
Prime Success, L.P. 8.1% 5,851,423 0 5,851,423 /s/ Yan Yang Yan Yang / Authorized Signatory
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .